1 / 40

Survey of Institutional Biosafety Committees

Survey of Institutional Biosafety Committees. Raymond W. Hackney, DrPH, CIH, CBSP University of North Carolina at Chapel Hill “The Future Face of Institutional Biosafety Committees…” San Diego, CA February 21, 2003. Purpose. Shed light on how IBCs are currently functioning

rolandt
Download Presentation

Survey of Institutional Biosafety Committees

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Survey of Institutional Biosafety Committees Raymond W. Hackney, DrPH, CIH, CBSP University of North Carolina at Chapel Hill “The Future Face of Institutional Biosafety Committees…” San Diego, CA February 21, 2003

  2. Purpose • Shed light on how IBCs are currently functioning • Assist institutions in administering their IBCs 

  3. Survey of IBCs • 9/02 An advance notice and questionnaires were mailed to 397 IBC contacts, listed with NIH (publicly available information) • 10/02 Reminder post card to non – responders • 11/02 Reminder email to non-responders

  4. Survey Response • 397 IBC contacts • 12 were returned without delivery • 4 formally declined to participate • 2 were completed by one respondent • 1 was removed from survey results (many questions were unanswered) • 168 completed questionnaires • 45 % response rate (adjusted)

  5. Institutions in Survey Population(397 IBC contacts)

  6. Institutions Participating in Survey(168 Survey Participants)

  7. Survey Participants Vs Survey Population Per Cent

  8. Person Completing Questionnaire (168 Respondents) per cent of respondents

  9. Institutional Office Responsible for IBC Other: IRB office Research & Sponsored Programs Other departments

  10. Position Responsible for IBC Faculty 19%

  11. Personnel Devoted to IBC

  12. Does the IBC Have Formal Policies?

  13. Is the IBC Required to Make Formal Reports?

  14. How Often Does the IBC Meet?

  15. By what mechanisms are committee meetings conducted?

  16. Are meetings open to the public?

  17. Have members of the public ever attended?

  18. If Yes, how often?

  19. Public Attendance at IBC Meetings

  20. Are IBC minutes available to the public?

  21. IBC Responsibilities

  22. Ensuring that rDNA Experiments are Reviewed

  23. IBC Membership

  24. Bacteriology 18% Physician 15% Virology 14% BSO 12% Animals 11% Plants 7% Other EHS 7% Other: 15% Molecular biology Research staff Legal counsel Administrators Expertise on IBCs% of total IBC members (1403)

  25. Community Membership

  26. Who Appoints IBC members?

  27. IBC Member Term of Service

  28. Formal Training for IBC Members

  29. Are there Procedures for Expedited Review?

  30. Conditions for Expedited Review Per Cent of Responses

  31. How Many rDNA Protocols Were Reviewed?

  32. Are Labs Inspected by BSO?

  33. Frequency of Lab Inspections Less often than Annually 23% Annually 51%

  34. Coordination with IACUC Per Cent of Responses

  35. Coordination with IRB Per Cent of Responses

  36. Coordination with IACUC(Corrected for “not applicable”) Per Cent of Responses

  37. Coordination with IRB(Corrected for “not applicable”) Per Cent of Responses

  38. Observations • Many IBCs are doing an excellent job • IBCs have limited resources • IBCs operate with high degree of informality • IBCs operate with low degree of involvement from institutional leadership

  39. RecommendationsIBCs can be strengthened by: • Provide more personnel resources to IBC • Require written policies and institutional accountability • Implement institutional controls to ensure compliance with the Guidelines • Ensure strict adherence to Guidelines despite IBC informalities • Provide training programs for IBC administrators and members

  40. Acknowledgements • Nancy King, UNC School of Medicine • Allan Shipp, NIH Office of Biotechnology Activities • 168 IBC Professionals who participated in the Survey

More Related